Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 7.12
+0.23 (3.34%)
May 29, 2026, 1:47 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 3.04 billion as of May 29, 2026. Its market cap has decreased by -44.51% in one year.
Market Cap
3.04B
Enterprise Value
2.92B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.12
Market Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 3.04B, a decrease of -40.38%. That is a compound annual growth rate of -13.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.04B | -12.39% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.44B |
| SCI Pharmtech | 4.86B |
| Easywell Biomedicals | 4.14B |
| Orient EuroPharma | 3.86B |
| Yoda Pharmaceuticals | 3.45B |
| Allied Biotech | 3.25B |
| Tien Liang BioTech | 3.01B |
| Maywufa Company | 2.83B |